Dow Jones 30 Stocks SEC Filings — February 05, 2026

06-02-2026

Virtus Investment Partners, Inc. filed an 8-K on February 6, 2026, under Item 2.02 disclosing results of operations and financial condition, accompanied by Item 9.01 for financial statements and exhibits. No specific quantitative metrics such as revenue, earnings, margins, or period-over-period changes are mentioned in the filing details provided. This is a standard earnings-related disclosure with no evident positive or negative performance indicators available.

• ·Multi-item 8-K filing (Items 2.02 and 9.01)
• ·AccNo: 0000883237-26-000004
• ·Filing size: 1 MB

06-02-2026

06-02-2026

Cantor Equity Partners VI, Inc. filed a Form 8-K on 2026-02-06 disclosing multiple items including Item 1.01 (Entry into a Material Definitive Agreement), Item 3.02 (Unregistered Sales of Equity Securities), Item 5.03 (Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year), Item 8.01 (Other Events), and Item 9.01 (Financial Statements and Exhibits). This is a multi-item mandatory filing with no specific transaction values, financial metrics, or performance comparisons provided.

06-02-2026

Marvell Technology, Inc. filed a Form 8-K on February 6, 2026, reporting under Item 8.01 Other Events and Item 9.01 Financial Statements and Exhibits. No specific details regarding the other events, financial statements, exhibits, or any quantitative metrics are disclosed in the provided filing information. This appears to be an informational disclosure without evident positive or negative performance indicators.

06-02-2026

Nine Energy Service, Inc. filed a Form 8-K on 2026-02-06 reporting entry into a material definitive agreement under Item 1.01 and creation of a direct financial obligation or off-balance sheet arrangement under Item 2.03. However, the filing also discloses a notice of delisting or failure to satisfy a continued listing rule or standard under Item 3.01, which signals significant compliance issues. Item 9.01 provides financial statements and exhibits, but no quantitative details such as transaction values, impacts, or metrics are disclosed.

06-02-2026

Qorvo, Inc. filed an 8-K on February 6, 2026, under Item 8.01 Other Events. No specific details regarding the event, financial metrics, transactions, or impacts are disclosed in the provided filing information. This is a single-item voluntary filing with undetermined materiality.

06-02-2026

SAFE & GREEN HOLDINGS CORP. filed an 8-K on 2026-02-06 disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers). Item 9.01 indicates Financial Statements and Exhibits were included. No specific details on the officer, position, reason for change, or any quantitative metrics are disclosed.

06-02-2026

Cannabist Co Holdings Inc. filed an 8-K on 2026-02-06 disclosing entry into a material definitive agreement under Item 1.01 and completion of an acquisition or disposition of assets under Item 2.01, accompanied by Regulation FD disclosure in Item 7.01 and financial statements/exhibits in Item 9.01. No specific transaction details, financial metrics, parties involved, or performance comparisons (positive, negative, or flat) were provided in the filing summary. All key deal terms remain NOT_DISCLOSED.

06-02-2026

Banc of California, Inc. filed an 8-K on February 6, 2026, disclosing under Item 8.01 Other Events and Item 9.01 Financial Statements and Exhibits. No specific details regarding the other events, financial statements, exhibits, or any quantitative metrics are provided in the filing summary. This appears to be a multi-item informational filing with no directional financial impacts or performance metrics disclosed.

06-02-2026

nVent Electric plc filed a Form 8-K on February 6, 2026 (AccNo: 0001628280-26-005930), disclosing results of operations and financial condition under Item 2.02, with financial statements and exhibits attached under Item 9.01. This is a multi-item earnings-related filing, typically voluntary disclosure. No specific revenue, earnings, guidance, period-over-period comparisons, or other quantitative financial metrics were provided in the filing excerpt.

06-02-2026

FARADAY FUTURE INTELLIGENT ELECTRIC INC. filed an 8-K on 2026-02-06 disclosing under Item 8.01 Other Events and Item 9.01 Financial Statements and Exhibits. No specific details regarding the nature of the other events, transaction values, financial metrics, or exhibit contents are provided in the filing metadata. This is a multi-item voluntary disclosure with no quantified positive or negative impacts reported.

• ·Accession Number: 0001213900-26-012984
• ·Filing size: 308 KB
• ·Sector: NOT_DISCLOSED

06-02-2026

MarketAxess Holdings Inc. filed a Form 8-K on 2026-02-06 reporting multiple events under Items 1.01 (Entry into a Material Definitive Agreement), 2.02 (Results of Operations and Financial Condition), 2.03 (Creation of a Direct Financial Obligation or Off-Balance Sheet Arrangement), 8.01 (Other Events), and 9.01 (Financial Statements and Exhibits). No specific transaction details, financial metrics, dollar values, percentages, or period-over-period comparisons are disclosed in the provided filing information. This multi-item filing indicates significant developments but lacks quantitative data for impact assessment.

06-02-2026

RenovoRx, Inc. filed an 8-K on 2026-02-06 disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers), along with Other Events in Item 8.01 and Financial Statements and Exhibits in Item 9.01. No specific details on the affected position, appointment or resignation, reasons, timing, or individuals involved are disclosed. No quantitative financial metrics, performance comparisons, or governance impacts are provided.

06-02-2026

Immunovant, Inc. filed an 8-K on February 6, 2026, reporting under Item 2.02 Results of Operations and Financial Condition and Item 9.01 Financial Statements and Exhibits. No specific financial metrics, period-over-period changes, revenue, earnings, guidance, or balance sheet impacts are disclosed in the provided filing information. This appears to be a standard voluntary disclosure of financial results with attached exhibits.

06-02-2026

Roivant Sciences Ltd. filed an 8-K on February 6, 2026 (AccNo: 0001635088-26-000009, Size: 391 KB), reporting under Item 2.02 Results of Operations and Financial Condition and Item 9.01 Financial Statements and Exhibits. No specific revenue, earnings, balance sheet details, period-over-period comparisons, guidance, or other quantitative financial metrics are disclosed in the provided filing information.

06-02-2026

Cboe Global Markets, Inc. filed a Form 8-K on 2026-02-06 under Item 2.02 disclosing results of operations and financial condition and Item 9.01 for financial statements and exhibits. No specific revenue, earnings, guidance, or other quantitative financial metrics are mentioned. This appears to be a standard mandatory earnings-related disclosure with attached exhibits.

06-02-2026

SPLASH BEVERAGE GROUP, INC. filed an 8-K on 2026-02-06 disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers), along with Regulation FD Disclosure under Item 7.01 and Financial Statements and Exhibits under Item 9.01. Specific details on the affected officer, position (e.g., CEO, CFO), nature of change (appointment or resignation), reasons, or timing are NOT_DISCLOSED. No quantitative financial metrics, performance comparisons, or governance impacts are mentioned.

06-02-2026

Wheeler Real Estate Investment Trust, Inc. filed a Form 8-K on February 6, 2026, under Item 8.01 disclosing an Other Event. No specific details on the nature of the event, financial metrics, transaction values, or impacts are provided in the filing summary. No positive or negative metrics are mentioned.

06-02-2026

PLAINS GP HOLDINGS LP filed an 8-K on February 6, 2026, reporting Results of Operations and Financial Condition under Item 2.02, Regulation FD Disclosure under Item 7.01, and Financial Statements and Exhibits under Item 9.01. No specific financial metrics, period-over-period comparisons, revenue, earnings, guidance, or other quantitative data are disclosed in the provided filing information. This is a multi-item filing likely related to quarterly or annual financial results.

06-02-2026

SpringBig Holdings, Inc. filed an 8-K on February 6, 2026 (AccNo: 0001213900-26-013048), disclosing an officer change under Item 5.02 related to Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers. No specific details on the key position affected, names of individuals, appointment or resignation status, reasons for the change, timing, or compensatory arrangements are disclosed in the provided filing summary. No quantitative data, financial metrics, or other implications are mentioned.

06-02-2026

Northfield Bancorp, Inc. filed an 8-K on 2026-02-06 disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers). The filing also references Item 9.01 (Financial Statements and Exhibits). No specific details such as officer name, position, reason for change, or any quantitative metrics are disclosed.

06-02-2026

Vroom, Inc. filed an 8-K on 2026-02-06 reporting under Item 1.01 entry into a material definitive agreement, while also disclosing under Item 2.03 the creation of a direct financial obligation or an obligation under an off-balance sheet arrangement. This represents a multi-item filing with no specific transaction details, dollar values, or terms provided. No positive or negative financial metrics, guidance changes, or strategic context are mentioned.

• ·AccNo: 0001193125-26-040495
• ·File Size: 166 KB
• ·Sector: not specified

06-02-2026

MOVING iMAGE TECHNOLOGIES INC. filed an 8-K on February 6, 2026, reporting Item 5.08 regarding Shareholder Nominations Pursuant to Exchange Act Rule 14a-11. No financial metrics, transaction details, or quantitative data are disclosed in the provided filing information. This appears to be a procedural disclosure related to shareholder rights.

06-02-2026

American Drive Acquisition Co filed an 8-K on 2026-02-06 disclosing Item 5.02 on departures of directors or certain officers, election of directors, appointment of certain officers, and compensatory arrangements of certain officers; Item 8.01 on other events; and Item 9.01 on financial statements and exhibits. No merger/acquisition details, quantitative metrics, parties involved, valuations, or strategic rationales are explicitly stated in the filing summary. No positive or negative financial impacts, changes, or comparisons are mentioned.

06-02-2026

06-02-2026

GameSquare Holdings, Inc. filed an 8-K on 2026-02-06 disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers), along with Regulation FD Disclosure under Item 7.01 and Financial Statements and Exhibits under Item 9.01. Specific details including the key position affected, whether it is an appointment or resignation, reasons for the change, and any named individuals are NOT_DISCLOSED. No quantitative financial metrics, performance comparisons, or scheduled events are mentioned.

06-02-2026

Liquidity Services Inc filed a Form 8-K on February 6, 2026 (AccNo: 0001193125-26-041166, Size: 225 KB), reporting under Item 8.01 Other Events and Item 9.01 Financial Statements and Exhibits. No details on the specific other events, transaction values, financial impacts, or exhibit contents are disclosed in the provided filing summary. No quantitative metrics, positive or negative changes, or strategic implications are mentioned.

06-02-2026

Saratoga Investment Corp. filed an 8-K on 2026-02-06 reporting Item 1.01 (Entry into a Material Definitive Agreement) and Item 2.03 (Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant), along with Item 9.01 (Financial Statements and Exhibits). No specific details on the agreement, transaction size, terms, or financial impacts are disclosed in the provided filing summary. No positive or negative metrics are mentioned.

06-02-2026

NanoVibronix, Inc. filed an 8-K on 2026-02-06 disclosing an officer change under Item 5.02, covering departures of directors or certain officers, election of directors, appointment of certain officers, and compensatory arrangements of certain officers. Item 9.01 indicates financial statements and exhibits were included. No specific details on positions, individuals, reasons, or impacts are disclosed.

06-02-2026

Vivos Therapeutics, Inc. filed an 8-K on February 6, 2026, disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers). Specific details including the key position affected, whether it is an appointment or resignation, reasons for the change, and any named individuals are NOT_DISCLOSED. No quantitative financial metrics, performance comparisons, or governance impacts are provided in the available information.

06-02-2026

06-02-2026

MultiSensor AI Holdings, Inc. filed a Form 8-K on 2026-02-06 under Item 1.02 announcing the termination of a material definitive agreement. No financial details, transaction size, parties involved, or impacts on operations or strategy were disclosed. This is a single-item mandatory filing representing a material event by definition.

06-02-2026

BlueLinx Holdings Inc. filed an 8-K on February 6, 2026, under Item 5.03 disclosing amendments to its Articles of Incorporation or Bylaws or a change in Fiscal Year, and under Item 9.01 listing Financial Statements and Exhibits. No specific details regarding the nature of the amendments, fiscal year change, or contents of exhibits are provided. No quantitative financial metrics, positive or negative changes, or performance comparisons are mentioned.

06-02-2026

HealthLynked Corp filed an 8-K on February 6, 2026, reporting under Item 1.01 entry into a material definitive agreement, Item 2.03 creation of a direct financial obligation or off-balance sheet arrangement, and Item 3.02 unregistered sales of equity securities, with Item 9.01 listing financial statements and exhibits. No specific transaction details, dollar values, share counts, financial metrics, or period-over-period comparisons are disclosed in the provided filing summary. The multi-item filing suggests potential dilution from equity sales and increased leverage from financial obligations, but lacks quantification.

06-02-2026

PMGC Holdings Inc. filed an 8-K on 2026-02-06 announcing the completion of an acquisition or disposition of assets under Item 2.01. The filing also includes other events under Item 8.01 and financial statements and exhibits under Item 9.01. No specific transaction details, financial metrics, parties involved, or performance impacts were disclosed.

06-02-2026

XCF Global, Inc. filed an 8-K on 2026-02-06 under Item 5.02 disclosing a departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. Item 9.01 indicates financial statements and exhibits were included. No specific details on positions affected, individuals involved, reasons for change, or any quantitative metrics were provided.

06-02-2026

APARTMENT INVESTMENT & MANAGEMENT CO filed an 8-K on February 6, 2026, under Item 5.07 disclosing the submission of matters to a vote of security holders, typically following an annual or special shareholder meeting. No specific proposals, vote outcomes, numerical tallies, or financial impacts are disclosed in the provided filing information. This is an informational filing with no quantitative metrics or directional implications provided.

06-02-2026

Travelers Companies, Inc. filed an 8-K on 2026-02-06 under Item 5.02 disclosing a leadership event involving departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. No specific details on affected positions, individuals, reasons for change, or financial impacts are provided in the filing summary. This appears to be a standard governance disclosure with no quantitative metrics or period-over-period comparisons mentioned.

06-02-2026

Eikon Therapeutics, Inc. filed an 8-K on February 06, 2026, reporting under Item 5.03 amendments to its Articles of Incorporation or Bylaws or a change in fiscal year, with exhibits attached under Item 9.01. No specific details on the nature of the amendments, fiscal year change, or any financial metrics are disclosed in the filing summary. This appears to be an informational governance update with no quantified impacts provided.

06-02-2026

MID PENN BANCORP INC filed an 8-K on February 6, 2026, reporting under Item 8.01 (Other Events) and Item 9.01 (Financial Statements and Exhibits). No specific details regarding the nature of the other events or the financial statements and exhibits are disclosed in the provided filing information. This is a multi-item filing with no quantitative metrics, transaction details, or performance comparisons provided.

06-02-2026

Vistagen Therapeutics, Inc. filed a Form 8-K on 2026-02-06 disclosing under Item 3.01 a notice of delisting or failure to satisfy a continued listing rule or standard, or transfer of listing. This represents a material negative event signaling non-compliance with exchange requirements. No quantitative financial metrics, positive developments, or additional details were disclosed.

06-02-2026

06-02-2026

NXP Semiconductors N.V. filed a Form 8-K on February 6, 2026, reporting under Item 1.01 entry into a material definitive agreement and under Item 2.03 the creation of a direct financial obligation or an obligation under an off-balance sheet arrangement. Item 9.01 discloses financial statements and exhibits. No specific transaction details, dollar values, strategic impacts, or financial metrics are provided in the filing summary.

06-02-2026

Verde Clean Fuels, Inc. filed a Form 8-K on February 6, 2026 (AccNo: 0001628280-26-006085, Size: 212 KB), reporting under Item 7.01 Regulation FD Disclosure and Item 9.01 Financial Statements and Exhibits. This is a multi-item voluntary disclosure, likely including a press release or update with attached exhibits, but no specific core event, transaction details, financial metrics, or directional data are disclosed in the provided filing summary. No positive or negative metrics are mentioned.

06-02-2026

Commercial Vehicle Group, Inc. filed a Form 8-K on February 6, 2026, reporting under Item 1.01 entry into a material definitive agreement, under Item 5.02 departure of directors or certain officers, election of directors, appointment of certain officers, and compensatory arrangements of certain officers, under Item 7.01 Regulation FD disclosure, and under Item 9.01 financial statements and exhibits. This is a multi-item filing with no specific details on the agreement, personnel changes, or disclosures provided in the available information. No quantitative financial impacts, transaction values, or other metrics are disclosed.

06-02-2026

Hennessy Capital Investment Corp. VIII filed a multi-item Form 8-K on February 6, 2026, reporting entry into a material definitive agreement (Item 1.01), unregistered sales of equity securities (Item 3.02), departure/election of directors or officers and compensatory arrangements (Item 5.02), amendments to articles of incorporation or bylaws (Item 5.03), other events (Item 8.01), and financial statements/exhibits (Item 9.01). No specific transaction details, financial metrics, dollar values, share counts, or named parties beyond the filer are disclosed. This appears to be a mandatory disclosure typical for significant corporate transactions such as potential business combinations.

06-02-2026

Veeco Instruments Inc filed an 8-K on February 6, 2026, reporting Item 5.07: Submission of Matters to a Vote of Security Holders, Item 7.01: Regulation FD Disclosure, and Item 9.01: Financial Statements and Exhibits. No specific vote results, disclosure details, financial metrics, or quantitative data are disclosed in the provided filing information. This multi-item filing provides informational updates without directional financial impact.

06-02-2026

Karman Holdings Inc. filed a Form 8-K on February 06, 2026, reporting under Item 1.01 entry into a material definitive agreement, Item 2.03 creation of a direct financial obligation or off-balance sheet arrangement, Item 7.01 Regulation FD disclosure, Item 8.01 other events, and Item 9.01 financial statements and exhibits. No specific details on the agreement, transaction size, financial terms, or impacts are disclosed. No quantitative metrics, period-over-period comparisons, or scheduled events are mentioned.

06-02-2026

Ascend Wellness Holdings, Inc. filed an 8-K on February 6, 2026, under Item 8.01 reporting Other Events. No specific details on the nature of the event, financial metrics, transactions, or impacts were disclosed in the filing information provided. This appears to be a single-item, potentially voluntary disclosure with no quantitative data available.

06-02-2026

United Parcel Service Inc filed an 8-K on February 6, 2026 (AccNo: 0001628280-26-006089), disclosing an event under Item 5.02 related to departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. No specific details such as names, titles, reasons for change, timing, or quantitative data are provided in the filing summary. No other financial metrics, comparisons, or events are mentioned.

06-02-2026

Universal Safety Products, Inc. filed an 8-K on February 6, 2026, disclosing unregistered sales of equity securities under Item 3.02. Item 9.01 includes financial statements and exhibits. No specific transaction details, values, or impacts are provided.

06-02-2026

Enveric Biosciences, Inc. filed a Form 8-K on February 06, 2026, reporting under Item 8.01 Other Events and Item 9.01 Financial Statements and Exhibits. No specific details on the nature of the other events, transaction values, financial metrics, or exhibits are disclosed in the filing summary. No positive or negative metrics are mentioned.

06-02-2026

FuboTV Inc. filed an 8-K on February 6, 2026, reporting under Item 5.07 the submission of matters to a vote of security holders, typically indicating results from a shareholder meeting such as an annual or special meeting. No specific proposals, vote outcomes, numerical results, or other details are disclosed in the provided filing information.

06-02-2026

M Evo Global Acquisition Corp II filed an 8-K on February 6, 2026 (AccNo: 0001213900-26-013321), disclosing other events under Item 8.01 and financial statements and exhibits under Item 9.01 in connection with a merger/acquisition. No quantitative metrics, deal terms, parties involved, valuations, synergies, or performance comparisons—positive or negative—are explicitly stated. Sector details are not specified.

06-02-2026

QT IMAGING HOLDINGS, INC. filed an 8-K on February 06, 2026, reporting under Item 8.01 Other Events and Item 9.01 Financial Statements and Exhibits. No specific details regarding the other events, financial statements, exhibits, transactions, metrics, or impacts are disclosed in the provided filing summary. This appears to be an informational filing with no quantified positive or negative developments mentioned.

06-02-2026

Presurance Holdings, Inc. filed an 8-K on February 6, 2026, reporting under Item 7.01 (Regulation FD Disclosure) and Item 9.01 (Financial Statements and Exhibits). No specific core events, transactions, financial metrics, or quantitative data are disclosed in the filing summary. This appears to be a voluntary disclosure of information under Regulation FD with attached exhibits.

06-02-2026

FIRSTSUN CAPITAL BANCORP filed an 8-K on February 6, 2026, reporting under Item 8.01 Other Events and Item 9.01 Financial Statements and Exhibits. No specific details on the nature of the other events, transaction values, financial metrics, or exhibits are disclosed in the provided filing summary. This appears to be an informational disclosure without quantified impacts.

06-02-2026

Adtalem Global Education Inc. filed an 8-K on February 6, 2026, disclosing amendments to its Articles of Incorporation or Bylaws or a change in fiscal year under Item 5.03, and Regulation FD Disclosure under Item 7.01, with exhibits under Item 9.01. No financial metrics, transaction values, or specific details on the amendments or disclosures are provided. This is a multi-item informational filing with no quantified positive or negative impacts disclosed.

06-02-2026

Aspire Biopharma Holdings, Inc. filed an 8-K on February 6, 2026, under Item 5.03 disclosing amendments to its Articles of Incorporation or Bylaws or a change in fiscal year. Item 9.01 indicates that financial statements and exhibits were attached. No specific details on the amendments, financial impacts, transaction values, or other metrics were provided.

06-02-2026

Catheter Precision, Inc. filed a multi-item Form 8-K on February 6, 2026, disclosing entry into a material definitive agreement (Item 1.01), unregistered sales of equity securities (Item 3.02), material modifications to rights of security holders (Item 3.03), and amendments to articles of incorporation or bylaws (Item 5.03), with exhibits under Item 9.01. These events suggest potential financing, dilution, and governance changes, but no specific transaction values, share counts, dollar amounts, or financial impacts are disclosed. No positive or negative metrics such as revenue, earnings, or balance sheet effects are mentioned.

06-02-2026

NeoVolta Inc. filed an 8-K on February 6, 2026 (AccNo: 0001683168-26-000848), disclosing information under Item 5.02 regarding Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers. No specific details on affected positions, individuals involved, reasons for change, or any quantitative metrics are disclosed. Sector information is not specified.

06-02-2026

VisionWave Holdings, Inc. filed an 8-K on February 6, 2026, reporting entry into a material definitive agreement under Item 1.01, other events under Item 8.01, and financial statements and exhibits under Item 9.01. No specific details on the agreement, events, transaction values, financial metrics, or impacts are disclosed in the provided filing summary. No positive or negative metrics are mentioned.

• ·Multi-item 8-K filing (Items 1.01, 8.01, 9.01)
• ·AccNo: 0001731122-26-000189, Size: 257 KB
• ·Sector: NOT_DISCLOSED